Genetic testing for MLH1 and MSH2 mutations is critical for individuals with a family history of Lynch syndrome-associated cancers. Testing usually involves sequencing the genes to identify pathogenic mutations. Positive test results can guide clinical management, including increased cancer screening and preventive measures such as prophylactic surgeries. Genetic counseling is recommended to help individuals understand the implications of their test results.
